PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34479861-1	2022	OBJECTIVE: To assess whether intermittent preventive treatment of pregnant women (IPTp) with sulfadoxine-pyrimethamine (SP) and azithromycin (AZI) in a malaria-endemic area leads to sustained gains in linear growth and development in their offspring.	Azithromycin	128-140	antizyme inhibitor 1	Homo sapiens	142-145	
27414503-13	2016	Reduced azithromycin susceptibility (Azi-RS) (defined as minimum inhibitory concentration [MIC] >=2.0 microg/mL) increased from 0.6% in 2013 to 2.5% in 2014.	Azithromycin	8-20	antizyme inhibitor 1	Homo sapiens	37-40	
34106964-1	2021	BACKGROUND: Hydroxychloroquine combined with azithromycin (HCQ/AZI) has initially been used against coronavirus disease-2019 (COVID-19).	Azithromycin	45-57	antizyme inhibitor 1	Homo sapiens	63-66